A new era in cancer research

Discoveries that offer hope

Cancer research at Université de Montreal and its affiliated institutions encompasses the entire discovery chain of drugs and treatments.

IRIC researchers

Researchers at the Institute for Research in Immunology and Cancer (IRIC) work to shed light on the mechanisms of cancer and speed up the discovery of new cancer therapies.

Anne MARINIER

MEDICAL CHEMISTRY

Claude PERREAULT

IMMUNOBIOLOGY

Guy SAUVAGEAU

HEMATOLOGY

Michel BOUVIER

PHARMACOLOGY

Sébastien LEMIEUX

BIOINFORMATICS

Delphine BOUILLY

BIOPHYSICS

udemnouvelles

5 November 2025

A study published in Science Immunology sheds light on why cancer immunotherapy doesn’t work for every patient or every type of cancer.

5 November 2025

A deeper understanding of immune “brakes” could lead to more effective therapies, according to a study co-authored by UdeM and IRCM researcher André Veillette.

5 November 2025

A deeper understanding of immune “brakes” could lead to more effective therapies, according to a study co-authored by UdeM and IRCM researcher André Veillette.

16 October 2025

A virus that’s genetically modified to strengthen the immune system increases the effectiveness of anti-cancer vaccines in mice, a new study suggests.

All news

Partnerships that accelerate new discoveries

Our research environments are firmly interdisciplinary and have solid ties to clinical practice. This speeds up the development of cancer therapies and gives new hope to patients and their families.

A pool of renowned researchers

Our researchers work to understand the mechanisms that lead to the emergence of cancer; they and their teams develop new therapeutic approaches and new drugs to treat different forms of the disease.